Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out How to Clean and Really focus on Your Lab Jewel - 2The Difficulties of Getting a Green Card in the US
- 3Whale stranded off Germany for days found stuck again
- 4Who is Artemis? Meet the Greek goddess who inspired NASA's return to the moon
- 5Pentagon advances Golden Dome missile defense with new Space Force contracts
- Brazil's ex-president Bolsonaro operated on for hernia
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- Collierville residents with no power as temperatures plunge
- New York to require social media platforms to display mental health warnings
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Bahrain cracks down on dissent as war grinds on
- Merck sees over $5 billion opportunity in Cidara's experimental flu drug
- French high-speed train slams into truck, killing TGV driver
- 5 Worldwide Road Food varieties You Should Attempt
